Animal biotech firm Gallant nets $11 mln
Gallant, an animal biotech firm, has raised $11 million in funding. The investors included Maveron, Bold Capital Partners, Bling Capital and Science Inc.
24 October 2019•1 min read
Gallant, an animal biotech firm, has raised $11 million in funding. The investors included Maveron, Bold Capital Partners, Bling Capital and Science Inc.
May River Capital agrees to $675m sale of Parameter Technologies to Acuity
6 hours ago · 1 min read
Onyx Partners strikes two-phase deal for Florida retailer Kane’s Furniture
7 hours ago · 1 min read
Kester-backed Evestia Clinical acquires Belgian medical writing firm Emtex in third add-on
7 hours ago · 1 min read
Weatherford Capital invests in Arnold Palmer Junior Golf Tour alongside Bolt Ventures
7 hours ago · 2 mins read
Permira agrees to buy Flint Group majority stake from General Atlantic
7 hours ago · 2 mins read
Transom strikes deal to carve out Cree LED from Penguin Solutions
8 hours ago · 2 mins read
Levine Leichtman makes growth investment in utility adviser Concentric Energy Advisors
8 hours ago · 2 mins read
